Skip to contentClarengateINTELLIGENCE
Coverage & freshness About Clarengate
Companies/15734758

Nuclide Therapeutics Ltd

Research and experimental development on biotechnology · London

ActiveUnited KingdomIncorporated 2024Private Limited Company
Register Ask analyst

Financial snapshot

Full financials
Period ended 2026-03-31GBPcompany accounts
Net assets
£1.94m+£1.94m vs 2025-03-31
Cash at bank
£1.93m+£1.93m vs 2025-03-31
Turnover
Not availableNot in extracted metrics
Employees
3+3 vs 2025-03-31

Balance sheet

GBP · company
2 comparable periodsSource filings

Company record

Company number
15734758
Incorporated
2024-05-22
Legal form
Private Limited Company
Registered office
124, CITY ROAD, LONDON, EC1V 2NX
SIC codes
72110
3 account filings heldExtraction validation findings recorded

People & control

View all
5Current role holders0Control records without an end date1Outstanding security records
OfficerOther current roles
0
0
0
0
0
No control records without an end date are available. Ownership is not established from this alone.

Activity timeline

9 records
  1. Accounts period ended

    GBP · 85 source facts

  2. Accounts period ended

    GBP · 85 source facts

  3. Security created

    Hsbc Innovation Banking

  5. Accounts period ended

    GBP · 44 source facts

Connected companies

Open network

No downstream companies resolved. Upstream control, where available, is shown in the network.

Capital & security

Outstanding charges1Reconstructed equity rounds0Matched research records0

Public records and extracted accounts. Missing figures are unknown, not zero. Research matches are not necessarily direct awards.